Clinical Trials: TMF / eTMF Management

Trial Master File (TMF) Management Best Practices

Posted on digi By digi

The Trial Master File (TMF) is the central repository of essential documents that collectively demonstrate compliance with Good Clinical Practice (GCP) and applicable regulatory requirements. For US sponsors, the FDA expects the TMF to provide a complete and contemporaneous record of a clinical trial. Proper TMF management is therefore critical for inspection readiness, trial credibility, and regulatory approval.

Click to read the full article.

Clinical Trial Operations & Compliance, TMF / eTMF Management

How eTMF Systems Improve Clinical Trial Oversight

Posted on digi By digi

The electronic Trial Master File (eTMF) has transformed how sponsors and CROs manage essential clinical trial documents. While the paper-based TMF historically fulfilled regulatory requirements, it was labor-intensive and error-prone. For US sponsors, FDA inspections increasingly expect a validated eTMF system that ensures contemporaneous, accurate, and accessible records. Effective eTMF implementation not only improves efficiency but also enhances inspection readiness and data integrity.

Click to read the full article.

Clinical Trial Operations & Compliance, TMF / eTMF Management

TMF Audit Readiness: Common Pitfalls and Solutions

Posted on digi By digi

The Trial Master File (TMF) is the cornerstone of inspection readiness for clinical trials. For US sponsors, FDA inspections under 21 CFR Part 312.57 focus heavily on TMF completeness and accessibility. Audit readiness means that a TMF must be contemporaneous, accurate, and inspection-ready at all times. Incomplete or disorganized TMFs are among the most frequent triggers of Form 483s during inspections.

Click to read the full article.

Clinical Trial Operations & Compliance, TMF / eTMF Management

Case Study: TMF Inspection Findings and CAPA Implementation

Posted on digi By digi

The Trial Master File (TMF) serves as the primary evidence that a clinical trial was conducted in compliance with Good Clinical Practice (GCP) and regulatory requirements. For US sponsors, FDA inspections under 21 CFR Part 312 and 21 CFR Part 11 frequently focus on TMF completeness and data integrity. Audit findings in TMF management often highlight systemic issues in document filing, oversight, and vendor compliance. Case studies provide valuable lessons on how sponsors can strengthen their TMF processes through effective Corrective and Preventive Actions (CAPA).

Click to read the full article.

Clinical Trial Operations & Compliance, TMF / eTMF Management

TMF Archiving and Long-Term Retention Strategies

Posted on digi By digi

Archiving and long-term retention of the Trial Master File (TMF) are crucial to demonstrate compliance with Good Clinical Practice (GCP) and regulatory requirements long after a trial ends. For US sponsors, the FDA requires trial documentation to be retained for specific periods under 21 CFR Part 312.57, ensuring data integrity and supporting potential post-approval inspections. Without robust archiving strategies, sponsors risk non-compliance, data loss, and reputational damage.

Click to read the full article.

Clinical Trial Operations & Compliance, TMF / eTMF Management

eTMF Vendor Selection: Criteria and Risk Considerations

Posted on digi By digi

The electronic Trial Master File (eTMF) has become the regulatory gold standard for maintaining essential clinical trial documents. For US sponsors, selecting the right eTMF vendor is critical to ensure compliance with FDA’s 21 CFR Part 11 and 21 CFR Part 312.57. Poor vendor selection can lead to inspection findings, data integrity concerns, and long-term operational risks. The FDA expects sponsors to demonstrate oversight of vendor systems, ensuring validation, audit trails, and secure access. Thus, vendor selection is not simply an IT procurement decision but a compliance-critical activity.

Click to read the full article.

Clinical Trial Operations & Compliance, TMF / eTMF Management